FHC #110: Diving deep into drug-pricing wizardry and deep learning (AI)

Like magicians, the U.S. biopharmaceutical industry has used diversion to distract the public’s attention away from where the real action is really happening. This Fixing Healthcare episode of Diving Deep begins with a look at three illusions drug companies have crafted to maintain massive profitability and keep Americans from  seeing important truths about pharma pricing, innovation and regulation.

Cohosts Dr. Robert Pearl and Jeremy Corr then focus on the future of generative artificial intelligence (GenAI). Despite 20-plus years of hype, AI’s impact on medical practice has been negligible thus far. But Pearl believes the next generation of AI is unlike any technology that has come before. The launch of ChatGPT in late 2022 marked the dawn of a new era in medicine. Pearl says that, in time, generative AI tools will “radically change healthcare, empower patients and redefine the doctor-patient relationship.”

Learn more about these two topics in today’s episode of Fixing Healthcare. Click play to learn more or check out the various links below for additional information.

HELPFUL LINKS

• The AI-Empowered Patient Is Coming: Are Doctors Ready? (Forbes)
• Dark Magic: Drug Companies And The Art Of Deception (Forbes)
• Monthly Musings on American Healthcare (Robert Pearl’s newsletter)

* * *

Dr. Robert Pearl is the author of a book about medicine’s invisible yet highly influential physician culture. Check out “Uncaring: How Physician Culture Is Killing Doctors & Patients.” All profits from the book go to Doctors Without Borders.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

The post FHC #110: Diving deep into drug-pricing wizardry and deep learning (AI) appeared first on Fixing Healthcare.